Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen

Hautklinik und Poliklinik

Klinikum / Johannes Gutenberg-Universität Mainz

Publikationen
Ergebnisse pro Seite:  10

Barwig, C; Raker, V; Montermann, E et al.

Antigen dose-dependent suppression of murine IgE responses is mediated by CD4(-)CD8(-) double-negative T cells

CLINICAL AND EXPERIMENTAL ALLERGY. Bd. 40. H. 6. 2010 S. 891-901


Mitzel-Kaoukhov, H; Muller, H; Groffik, A et al.

Asymptomatic neurocutaneous melanosis in association with Dandy-Walker-Syndrome: long term follow-up report

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 8. H. 9. 2010 S. 760-760


Klein-Gonzalez, N; Balkow, S; Kondo, E et al.

Basic Science Award CD40-activated B-cells migrate towards secondary lymphoid organs and interact dynamically with T-cells

BONE MARROW TRANSPLANTATION. Bd. 45. 2010 S. S1-S1


Bork, K; Hardt, J

C1 Inhibitor Therapy and Hereditary Angioedema The Reply

AMERICAN JOURNAL OF MEDICINE. Bd. 123. H. 4. 2010 S. E17-E17


Tuettenberg, A; Fondel, S; Steinbrink, K et al.

CD40 signalling in dendritic cells: Balance between immunity and tolerance

EXPERIMENTAL DERMATOLOGY. Bd. 19. H. 2. 2010 S. 190-190


Tuettenberg, A; Fondel, S; Steinbrink, K et al.

CD40 signalling induces IL-10-producing, tolerogenic dendritic cells

EXPERIMENTAL DERMATOLOGY. Bd. 19. H. 1. 2010 S. 44-53


Proebstle, TM

Cellulite

HAUTARZT. Bd. 61. H. 10. 2010 S. 864-872


Bacher, N; Graulich, E; Lorenz, N et al.

Comparative analyses of CD4+and CD8+T cells in melanoma patients after high-versus intermediate-dose interferon-alpha therapy

EXPERIMENTAL DERMATOLOGY. Bd. 19. H. 2. 2010 S. 190-190


Kautz-Neu, K; John, D; Dinges, S et al.

Control of anti-Leishmania immunity: Suppression by epidermal Langerhans cells versus healing promoted by CD11c+dendritic cells

EXPERIMENTAL DERMATOLOGY. Bd. 19. H. 2. 2010 S. 201-201


Nir, Y; Friederike, F; Dominika, L et al.

Dendritic cells control tolerance in EAE via the induction of Tregs by the PD-1 signalling pathway

JOURNAL OF NEUROIMMUNOLOGY. Bd. 228. H. 1-2. 2010 S. 114-115